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INTRODUCTION 
The primary factors Involved in the regulation of blood pressure 
are the cardiac output, peripheral resistance and the circulating blood 
volume. The systolic pressure is chiefly dependent upon the cardiac output, 
whereas the diastolic blood pressure mainly reflects the peripheral r e s i s -
tance in the ar ter ies (Mellander, 1960). Both cardiac output and peripheral 
resistance are under the control of the autonomic nervous system. 
The central nervous system (CNS) is known to influence and domi-
nate the autonomic nervous system. It i s , therefore, not surprising that 
the CNS is also involved in the regulation of blood pressure . Certain r e -
gions in the medulla oblongata and the hypothalamus, which upon stimulation 
produce changes in blood pressure, are known to be involved since a long 
time (Schmitt and Schmitt 1969). 
Claude Bernard (1878-1879) first observed that a section of the 
spinal cord in the lower cervical region caused a fall in blood pressure 
indicating the importance of CNS. Cynon and Ludwig (18 66) found that 
stimulation of the central end of the cut nerve lying parallel but separate 
from the cervical vagus caused bradycardia and hypotension. In 1870, 
Dittmar showed the importance of a structure in the medulla oblongata 
in the maintenance of normal blood pressure. 
The control of the activity of the cardiovascular system by the 
CNS is highly complex. It is apparent that various neuronal populations 
containing different transmitter substances interact intr icately to maintain 
a homeostatic balance of the cardiovascular system. Various authors have 
suggested that central mechanisms are involved in certain forms of hyper-
tension. Drugs have, therefore, been developed which lower blood pressure 
via their influence on certain parts of the central nervous system. 
The lowering of raised blood pressure is a pharmacological effect 
of numerous compounds, some of which are suitable for the treatment of 
hypertension. The onset, degree and duration of the blood pressure lowering 
effect, the mode of action, the occurrence of s ide effects and adverse, 
reactions are only some features that eventually determine whether a hypo-
tensive agent can become an antihypertensive drug. A detailed knowledge 
of the areas in the CNS and the study of the involved receptors is vital 
in the understanding of the mechanism of action of antihypertensive drugs. 
Studies indicate that various adrenergic, cholinergic, dopaminergic, 
serotonergic and GABAergic receptors are directly or indirect ly involved 
in blood pressure regulation. The o(-adrenoceptors, mainly located post 
synaptical ly, in the region of the NTS are involved in the lowering of 
blood pressure (ilejong, 1974). 
The cholinergic neurons are widely distributed in the CNS and 
the cholinergic agents can enter CNS freely. Certain areas in the brain , 
l ike the hypothalamus and area postrem of medulla are involved in central 
and peripheral cholinergic mechanisms (Bhargava, 1973). 
Dopaminergic neurons in the midbrain and dorsal hypothalamus 
are also said to be responsible in blood pressure control. Central dopa-
minergic system plays an important role in hypertension (Bhargava, 1983) 
Dopamine itself induces a fall in blood pressure mainly after perfusion 
in the anterior part of the third ventricle. Serotonergic neurons are present 
in the brain stem, hypothalamus and spinal cord. There are many interac-
tions between the central serotonergic and sympathetic systems in relation 
with the cardiovascular regulation^ \ ? - .> GABAergic 
mechanism is also involved in the central blood pressure regulation since 
such neurons are present throughout the brain with high concentrations 
in the hypothalamus and substantia nigra. Exogenous administration of GABA 
or muscimol leads to hypertension or hypotension possibly by an inhibitory 
influence on pressor pathways in the brain. Since anti-hypertensive therapy 
consists of treatment with drugs which may have primary action in CNS 
or outside. We have taken four antihypertensive drugs for our study. The 
proposed mechanism of action of each of these drugs is different but the 
effect of their long term administration on the brain receptors is not known 
but .is of vital importance. 
Clonidine ^[Catapres, Catapsesan) was synthesised by Stable in 
1962 and originally tested preclinically as a niisal decongestant because 
of i t s vasoconstrictor proper t ies . Later experiments by Graubner and Wolf 
(1966) indicated that it possessed other pharmacological propert ies like 
reducing heart r a t e , lowering blood pressure and causing sedation. Today 
clonidine is accepted as a potent antihypertensive agent with a predojninantly 
central mode of action. Considering its chemical relationship to various 
sympathomimetic agents it is not surprising that clonidine influences adre-
nergic receptors both in the periphery and in the central nervous system 
(Anden £t_ al_. 1970), Chronic clonidine therapy produces a persistent reduc-
tion in arterial pressure. 
Rmwolila 6eApenUna is the plant from which reserpine (Bein, 
1956) was isolated and used in Indian medicine for the treatment of various 
disorders for centuries. It was brought to the notice of Western medicine 
only in 1949 by Vakil. Reserpine is widely used in the therapy of hyper-
tension, particulariy in combination with other drugs. Reserpine lowers 
arter ial pressure in hypertensive and normotensive animals and man. The 
depletion of catecholamine stores has been recognized to be an important 
mechanism in the antihypertensive action of reserpine and related compounds. 
Since noradernaline is the most important neurotransmitter in the peripheral 
adrenergic system, the depletion of this neurohumour will probably have 
a negative effect upon the activity of the sympathetic nervous system. 
The depletion of noradrenaline stores caused by reserpine is not limited 
to the peripheral adrenergic system but also extends to the CNS where 
it is present in high concentrations. The hypotensive action of reserpine 
can therefore, be both the peripheral and central action. 
Hydralazine was discovered by Druey and Coworkers in 1945. Al-
though hydralazine was originally thougiit to reduce blood pressure by 
a central action, it is now accepted that these effects are only minor 
of 
and that the major site of action resides at the l eve l /vascu la r smooth 
muscle (Baum e1^  al .^ 1972; David et^  al_. 1975). 
Centhaquin - was synthesized in C D . R.I. in 1971, It was found 
to lower blood pressure in several species of animals in low doses. The 
main site of action was found to reside in the CNS (Srimal et a l . 1978). 
However, the exact mechanism of i ts action is not yet known. It was also 
found to lower the blood pressure of hypertensive pat ients . 
METHODOLOGY AND TECHNIQUE 
Albino rats of the Charles Foster s t ra in , bred in the animal house 
of the Central Drug Research Institute were used. Rats weighing 100-150 
gE". were taken and kept in standard laboratory conditions of temperature, 
humidity and dark light cycle. 
Antihypertensive drugs, clonidine (0.1 mg/kg) was dissolved in 
water, centhaquin (0.1 mg/kg) synthesised in the Central Drug Research 
Institute and was dissolved in /a lcohol . Dihydralazine (0.125 mg/kg) made 
by Ciba Geigy. of India Ltd. was diluted in water. Reserpine (Serpasil) 
(12.5 mg/kg) made by Ciba Geigy of India Ltd. was diluted in water. 
These drugs were orally administered daily for two months to groups of 
20 r a t s . 
Preparation of Membranes with Receptors 
Animals were sacrificed and decapitated at the end of two months. 
Specific areas of the brain like the hypothalamus, cortex, caudate and 
medulla were dissected out in cold. Each brain area was weighed and 
then homogenized in 30 volumes of ice cold 50 nM Tris HCl buffer (pH 
7.4 at 20''C) containing 0.1% ascorbic acid, 120 nM pargyline, 5 mM pota-
ssium chloride, 2 mM calcium chloride and I mM magnesium chloride. The 
neuronal membrane was prepared by centrifugation at 2,000 g for 10 minutes, 
pellets were discarded and the supernatant was recentrifuged twice at 
50,000 g for 15 minutes each. This time the supernatant was discarded 
and the pellets were weighed and suspended in 50 mM Tris buffer (pH 
7.4 at 37°C). 
The standard assay mixture containing different concentraions of 
the hot l igands, fixed concentration of cold ligand and 200 ug of the neuro-
nal membrane and buffer to make up the total volume of I ml was incubated 
in tr ipl icate in a shaking water bath at 37°C for 15 minutes. The reaction 
was discontinued by dipping the tubes in ice cold water. The contents 
of the incubated tubes were rapidly filtered under partial vacuum using 
a Millipore Manifold filtration unit and Whatman GF/C glass fibre f i l t e r s . 
This was followed by three washes with 5 ml ice cold 50 mM Tris buffer 
(pH 7.4). The dried discs were transferred to sci-'ntillation liquid [Compo-
sition: 2,5-diphenyloxazole 4.9 M; 1,4-bis (5-Phenylonazolyl) benzene 
200 mg; naphthalein 60 g, ; ethylene glycol 20 ml; methanol 100 ml; dio-
xane upto 1 l i t r e ) ] . After an overnight equilibration per iod, the radio 
act ivi ty in the sample was counted by LKB Rack beta 1217 liquid sciuntilla-
tion spectrometer. 
It is necessary, to differentiate between the two types of binding 
that takes place under these circumstances, that i s , specific to the recep-
tor vinder investigation and non-specific to the other biopolymers of the 
t issue. The number of specific receptor sites are limited whereas the 
non-specific sites are unlimited. The binding experiment was, therefore, 
repeated in the presence of excess amount of non-radio-labelled ligand. 
Under these conditions it is unlikely that any radio labelled ligand would 
bind to the specific sites while non-specific binding was unaffected. The 
difference in the binding values for these two experiments then gave the 
amount of specific binding. Repeating the two experiments for a range 
of labelled ligand concentrations helps in plotting down the resul t s . This 
clearly shows that the amount of specifically bound ligand reached a maxi-
mum despite the addition of increasing amounts of ligand. This situation 
would be expected if the number of specific receptors are limited. Such 
curves are capable of the mathematical analysis common to similar bioche-
mical studies from which dissociation constants and the number of receptor 
sites are determined. 
An extension of these studies is to investigate the binding process 
in the presence of agents thought to act as agonists or antagonists for 
that particular receptors which were being studied. Varying amounts of 
the compound under investigation were added to the incubation medium 
which contained a fixed amount of labelled ligand; the amount of specific 
binding is plotted against the concentration of the added compotmd. 
Receptor Binding Studies 
Adrenergic and dopaminergic receptors were taken for the radio-
active receptor binding studies. 
The hot ligand used for the oC-adrenergic receptors was 3H-Dihydro-
ergocriptine (Amersham). Different concentrations from 0.25 to 12nM ' were 
used. Cold ligand used was phentolamine (1 uM). 
For the fi -adrenergic receptors 3H-Dihydroalprenalol (Amersham) 
was used as the hot ligand at concentrations ranging from 0.12 nM to 4nM. 
Propranolol at a fixed concentration of 1 uM was taken" as the cold ligand. 
For dopaminergic receptor binding assays 3H-Spiperone (NEN) at 
concentrations of 0.1 nM to 5 nM was used as hot ligand. Haloperidol at 
a fixed concentration of 1 uM was taken as the cold ligand. 
All the experiments were repeated thrice and the data was analysed 
using least square regression analysis and analysis of variance. 
REVIEW OF LITERATURE 
HYPOTHALAMUS 
Brezenoff and Jenden (1969) r e p o r t e d tha t injection of noradrena l ine 
into the pos te r io r hypothalamus of r a t s r e su l t ed in a s l i g h t and s h o r t 
l i ved r i s e of blood p r e s s u r e . E lec t r ica l s t imulat ion of va r ious nuclei of 
the hypothalamus led to an enhanced r e l ea s e of r a d i o - a c t i v e no rad rena l ine 
which had been ea r l i e r injected in the l a t e r a l ven t r i c l e ( P h i l i p p u , 1970). 
It has been suggested tha t p^ r a t h e r than ^ - ad renocep to r s of the h y p o -
thalamus a r e involved in the p r e s s o r response (Ph i l ippu and K i t t e l , 1977). 
Superfusion of hypothalamus with procaine at a concentrat ion which was 
equ ianaes the t i c to tha t of propranolol ( P h i l i p p u , 1970', Ph i l i ppu and K i t t e l , 
1977) was ineffective in prevent ing noradrenal ine effect . Microinjection 
of clonidine into the pos te r ior hypothalamus of r a t led to a fall in blood 
p r e s s u r e and hea r t r a t e (Struyker Boudier et^ al^., 1972). It was presumed 
tha t the hypotens ive act ion of c lonidine was p a r t l y due to i t s ac t ion on 
the n o r - a d r e n e r g i c system of the pos te r io r hypothalamus (S t ruyker Boudier, , 
et a l . . 1972). Phi l ippu et^ al_. , (1973a) p rov ided ev idence for the ac t ion 
of c lonidine on both p r e - and pos t - synap t i c r ecep to r s of pos t e r io r h y p o t h a -
lamus in ca t . Injection of clonidine into the l a t e ra l ven t r i c l e of ca t s i n h i b i -
ted the p re s so r response to e l ec t r i ca l s t imulat ion of the hypo tha lamus 
(Dhawan et_ al_., 1975). 
Bhargava (1984) , suggested tha t cyclo (Leucyl-glycine) i n t e r ac t s wi th b r a i n 
dopamine r ecep to r s and tha t b ra in dopamine r e c e p t o r s may be invo lved 
in the et iology of hype r t ens ion . He also found a number of (3H) s p i r o p e r i -
dol binding s i t e s in the hypothalamus of spontaneously h y p e r t e n s i v e r a t s 
(SHR). In e a r l i e r s tud ies Bhargava , (1983 ) has ind ica ted t h a t chronic 
t reatment of SHR with CLG - inhibi tes the enhanced hypo the rmic r e sponse 
to apomorphine . 
The pa raven t r i cu la r nucleus of the hypothalamus (PVNH) has been 
suggested to p a r t i c i p a t e in the control of the autonomic nervous s y s t e m , 
p a r t i c u l a r l y the ca rd iovascu la r functions (Kannan and Yamash i ta , 1985). 
This nucleus has been shown to r ece ive a v a r i e t y of ca rd iovascu la r af ferent 
information (Calaresu and C i r i e l l o , 1980). The s t imulat ion and les ion of 
the PVNH area have been r e p o r t e d to modify ca rd iovascu la r functions (Zhang 
and C i r i e l l o , 1982). 
Neuroanatomical s tud ies demonstrate tha t the PVNH neurons send 
axons to the lower brains tem and the spinal cord including the nucleus 
t r ac tus so l i t a r ius (NTS) and the in termedio la te ra l cel l column of the sp ina l 
c o r d , which may u l t imate ly control ca rd iovascu la r function (Mnltra et_ a l . t 
19W). Some neurons which project to the dorsomedial medulla r ece ive 
afferent information from ca ro t id ba ro recep to r and i t suggests t h a t PVNH 
may p lay a ro le in the neural control of the ba ro recep to r re f lex a t the 
level of the NTS region (Kannan and Yamashita , 1985). 
Cir iel lo ,^ Caver son (1986) suggested tha t e levat ion of a r t e r i a l p r e -
s su re obse rved following lesion of the PVNH was not due to des t ruc t ion 
of i t s neurons , but i t was a non-specif ic effect of the les ion of the b ra in 
t i s s u e . Elec t r ica l s t imulat ion of PVNH e l i c i t s increase in the a r t e r i a l p r e -
ssure and the hear t r a t e . 
NUCLEUS TRACTUS SOLITARIUS (NTS) 
The nucleus t r ac tu s so l i t a r ius (NTS) i s t h e s i t e of terminat ion 
of afferent f ib res from a r t e r i a l and cardiopulmonary mechanoreceptors and 
chemoreceptors (Muira and Reis , 1969). It thus mediates and in tegra tes 
the barorecep tor re f lex (Muira and Reis , 1972). 
The NTS is thought to be the s i t e of action of noradrena l ine con-
taining neurons which have been found in t h i s nucleus (Dahlstrom and Fuxe , 
1965). Injection of catecholamines including alpha'methyl noradrena l ine into 
the NTS causes decrease of blood p r e s s u r e and hea r t r a t e (ctsjong, 1974). 
This may be the r e s u l t of d i r ec t st imulation of post synap t i c a l p h a - a d r e n o -
ceptor . ' The most sens i t ive region for t h i s action 
i s A (Dahlstrons and Fuxe , 1964). Alpha, type of ad renocep to r s a r e thought 
to be involved in b r a d y c a r d i a (dejong, 1974). 
Infusion of c lonidine into t h i s nucleus has been r e p o r t e d to reduce 
b l o o d - p r e s s u r e and h e a r t r a t e (Sinha et^ al_. , 1975). However, consenses 
i s t ha t the NTS is not the only or the main s i t e of t h e hypo t ens ive action 
of clonidine in cats and dogs . 
Laguzzi et^ al_., (1984) have suggested tha t a l though serotonergic 
mechanisms in the NTS may be involved in the modulation of e l e c t r o - c o r -
t ica l and card iovascu la r a c t i v i t y , t h e y a r e not i n t e g r a r to the ba ro recep to r 
re f l ex a r c . Sved (1985) ind ica ted tha t hyper tens ion by b i l a t e r a l NTS d e s -
t ruc t ion in r a t s is p roduced by complex in terac t ions among t h e sympa tho-
adrenal systems vasopressin and the renin-angiotensin system. 
MEDULLA 
The ventral surface of the medulla oblongata (VSMO) is the focus 
of attention as an important brain region in the central regulation of the 
cardiovascular system. The basis for this interest lies largely in functional 
studies carried out in cats and rabbi ts . Bousquet and Guertzenstein (1973) 
claimed that the site of action of clonidine is located on a small area 
of the ventral surface of medulla oblongata called Schlafke zone. Clonidine 
applied in small concentration on this area induced a marked fall in blood 
pressure and caused bradycardia. This was confirmed by Dhawan et_ al. , 
(1975), Bousquest ei^ al., (1975 ) further reported that bilateral destruction 
of this area abolished the depressor effect of clonidine. Reis and Coworkers 
(1984) have provided evidence that adrenaline containing neurons of C^ 
area may represent the tonic vasomotor neurons of the rostral ventrolateral 
medulla. They have hypothesized that the decrease in blood pressure 
provoked by clonidine is mediated via a decrease in adrenaline turnover 
in the A^/C area. Electrical stimulation, glutamate microinjection or kainic 
acid application to the ventral medulla raises ar ter ial blood pressure 
(McAllen et_ ah., 1982). Bilateral destruction with electrolytic lesions, cold 
block, or neurotoxic doses of kainic acid lower blood pressure (McAllen 
et a l . . 1982). This area is highly chemosensitive. Three specific areas 
( ros t ra l , intermediate and caudal) in this region of medulla have been 
defined according to the cardiovascular and ventilatory effects elicited 
by topical application of various agents . (Schlaefke, 
1981). However, the intermediate zone is the area from which the most 
profound cardiovascular effects have been evoked (McAllen et^  al_., 1982; 
Keeler e^ al^., 1984). 
When topically applied to cat VSMO, GABA and i ts potent agonist, 
musimol, produced depressor and bradycardiac responses. These responses 
were reversed by similar application of the specific GABA receptor anta-
gonist bicuculline (Yamada et al., 1982). These studies suggested that GABA-
ergic system' in the VSMO in the cat is inhibitory to sympathetic out flow 
(Keeler et^  al_., 1984). 
Sved et^  al^., (1985) have indicated that vasopressin release and 
arterial pressure responds differently to treatments of the caudal ventro-
lateral medulla, suggesting that different cells in the caudal ventrolateral 
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medulla are involved in the regulation of vasopressin release and arter ial 
pressure . 
The cardiovascular effects associated with the micro-injections 
of carbachol, phytostigmine and atropine, into the pressor area of ventro-
lateral medulla were studied by Willete et^  al_. , (1984). They found that 
the hypertensive responses evoked by muscarinic-receptor stimulation in 
the ventrolateral medulla were mediated by increased sympathetic ac t iv i ty . 
Ciriello and Caverson (1986) suggested that neurons in the ventro-
lateral medulla may be a medullary feed back reflex loop though which 
afferent information from cardiovascular receptors exer ts an influence on 
NTS neurons involved in the control of the circulation. 
Smialowska et_ a2_. » (1985), by histological examination and scanning 
electron microscopy of the medulla oblongata, found that there is a wide 
dense area of catecholamine terminals in the external layer of the ventral 
medulla oblongata. 5-Hydroxytryptamine-containing terminals and nerve 
cell bodies on and near the surface were also found. They suggested that 
due to their superficial location these monoamine nerve terminals may in-
fluence the content of cerebrospinal fluid and in this way have effects 
on cardiovascular and other physiological functions. 
CAUDATE NUCLEUS 
The corpus striatum comprises of caudate nucleus, putamen and 
globus pallidus. The size of the caudate nucleus depends upon the size 
of the cerebral cortex. It has a large head which tapers to a body and 
then' t a i l . The large bulbous head forms the lateral wall of the posterior 
horn of the lateral ventricle. Caudate nucleus receives afferent input from 
the thalamus, subthalamus, cerebral cortex, brainstem nuclei and substantia 
nigra. 
The main afferent projection from caudate is to the globus pal l idus , 
thalamus, subthalamus, brain stem nuclei, olivary nuclei and substantia 
nigra. 
.Neurons which contain dopamine are found with cell bodies in 
substantia nigra and terminals in the caudate nucleus (Anden et_ al_., 1970). 
It has been shown that there is a close relationship between the two nigro-
str iatal dopaminergic pathways in cat and rat (Hull et a l . , 1974). 
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Elec t r ica l s t imulat ion of caudate nucleus r e l ea ses dopamine in the 
ven t r i cu la r sys tem (Goldstein et a l . . 1969). 
CLONIDINE 
History 
Clonidine was syn thes i sed in 1962 by Stable as a d e r i v a t i v e of 
the imidazol ine nuc leus , the vasoconst r ic tor p r o p e r t i e s of which were well 
known, in the hope tha t i t would be a nasal decongestant . It caused cons i -
de rab l e consternat ion, when after the nasal ins ta l l a t ion of a few d r o p s , 
the f i r s t two volunteers to rece ive c lonidine became ve ry seda ted and 
hypo tens ive (Graubner and Wolf, 1966). This chance finding t r igge red a 
large number of inves t iga t ions (Nayler et_ ah., 1968', McRaven et^ al_., 1971) 
which have shown tha t clonidine is an effect ive cen t r a l ly act ing a n t i h y p e r -
tens ive agent . 
Mechanism of Action 
Clonidine produces an in i t ia l increase in blood p r e s s u r e followed 
by a f a l l . The in i t i a l increase in blood p r e s s u r e was found to be due 
to s t imulat ion of p e r i p h e r a l ad renocep to r s . The h y p e r t e n s i v e effect was 
eas i e r to inves t iga te after suppress ion of the sympathe t i c tone by s p i n a l i -
zation (Constantine and McShane, 1968), p i th ing (Autret et^ al_., 1971), admi-
n i s t r a t ion of ganglion blocking agents and (Boisser et^ al_. 1968; Nayler 
et a l . , 1968), resei :pine (Boissier et^ a\_., 1968) guanethidine (Robson and 
Kaplan, 1969) or b re ty l ium (Nayler et_ al_., 1966). 
Phenoxybenzamine has been r e p o r t e d to be a poor antagonist of 
c lonidine induced hyper tens ion in cat (Nayler et^ aj_., 1966) but o t h e r s have 
r e p o r t e d i t to be effect ive in dogs and r a b b i t s (Nayler et^ ah., 1968) as 
well as ca t (Schmitt and Schmitt 1970). 
I t has been demonstrated tha t c lonidine ac t s as a sympathomimetic 
agent on J^-adrenoceptors . L ipski et^ al_., (1976a) found tha t b i l a t e r a l d e s -
t ruct ion of the nucleus t r ac tus so l i t a r i i induced in u re than ized r a t s a r i s e 
in blood p r e s s u r e and. reduced the hypotens ive effect of c lon id ine . 
The effects of clonidine on ^ - a d r e n o c e p t o r s a p p e a r to be v e r y 
weak or a b s e n t . In the i so la ted aur ic le of guinea p i g s , c lonidine in high 
concent ra t ion , i nc reased the cont rac t i le force but d id not change the r a t e 
(Hoefke and Kobinger, 1966). On the h e a r t lung p r e p a r a t i o n of the dog 
(Hoefke and Kobinger 1966) or in the i so la t ed h e a r t of the cat (Constantine 
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and McShane, 1968) or the rabbit (Werner et_ aj_., 1972) clonidine reduced 
the contractile force only at high concentrations. All these investigations 
demonstrate that clonidine is an oC-sympathomimetic agent and is probably 
not taken up by the sympathetic nerve terminals. 
Clonidine appears to be a partial agonist on ^ - a d r e n o c e p t o r s ; 
in fact the maximum effect was less than that of noradrenaline on rabbit 
pulmonary ar tery (Starke ejt^  a2_.. 1974). 
Mechanism of Hypotension 
Low doses of clonidine caused hypotension and bradycardia in 
dog, cat and rat (Boissier et_ al_., 1968). This potential of hypotension 
and bradycardia can be explained in part by loss of the reflex inhibition 
of the sympathetic tone after clonidine, thus the vascular smooth muscle 
is unopposed in i ts response to the pressor agents. However, since noradre-
naline is also potentiated after clonidine in pithed rats (Boissier et_ al . , 
1968) some peripheral component must also be involved. In man, no signi-
ficant interaction of clonidine with catecholamines was observed (Onesti 
et_ al_., 1971). 
In high doses, clonidine reduced the effect of noradrenaline and 
sometimes reversed the hypertensive effects of adrenaline (Boissier et^  
a l . > 1968). Coupar and Kirby (1972) suggested that clonidine may cause 
venodilation by blocking endogenously released noradrenaline, an effect 
which may contribute to the hypotensive action of the drug. 
The concept that a pre-synaptic of-adrenoceptor stimulation could 
inhibit noradrenaline release is generally accepted (Starke et^  al_., 1975). 
Phentolamine increases noradrenaline release and in addition antagonises 
the effect of clonidine (Starke et^  a2^.. 1974). Since the f i rs t synapses of 
baroreceptor fibres are located in the nucleus tractus sol i tar i i (NTS) , 
it is thought that clonidine night mimic the effects of baroreceptor stimula-
tion. Greenberg and Wilborn (1982) suggested that clonidine 
may act directly on the veins, or indirectly by inhibiting the release 
or synthesis of a trophic noradrenergic factor, to reverse the functional 
and structural changes in the veins. Lorez et_ al^.. (1983) proposed that 
the effect of clonidine on noradrenaline turnover is most l ikely the result 
of a local feed back inhibition through presynaptic 0(-adrenoceptors. Medgett 
and Rand (1983) suggested that since the NTS and intermediolateral cell 
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column of the spinal cord are the prime centers for the site of the cardio-
vascular action of clonidine and since the cardiovascular effects of clonidine 
can be elicited in the virtual absence of neuronal noradrenaline, the de-
crease in central noradrenaline turn over and the cardiovascular effects 
of clonidine are not interrelated phenomena. Bentley e t _ ^ . , (1986) suggested 
that clonidine causes a selective reduction in sympathetic tone to the veins 
that is mediated at least partly by a central action as well as an expan-
sion of the collateral venous routes. This together with the selective im-
pairment of venoconstrictor responses to both noradrenaline and adrenaline, 
may account for the decrease in cardiac output that is most often reported 
following clonidine, 
Clonidine in hypertensive patients reduced the excretion of urinary 
catecholamines (Hokfelt et_ al_., 1975). This effect is believed to be due 
to the decreased sympathetic tone. Clonidine does not change the level 
of catecholamines in the brain (Hoefke and Kobinger 1966; Persson and 
Waldeck, 1970; Bralet £t_ ail^ ., 1973). A slight increase in noradrenaline 
or dopamine levels has been reported after high doses of clonidine (Persson 
and Waldeck, 1970). The increased dopamine levels in the corpus striatum 
could account for the stereotypes seen with high doses of the drug (Persson 
and Waldeck, 1970). 
The elevation of cerebrospinal fluid and noradrenaline act ivi ty 
may be increased in patients with mild to moderate essential hypertension 
and that can be reduced by treatment with clonidine (Cubeddu et_ a]_., 1984). 
Stimulation of peripheral prejunctional pC ^-adrenoceptors in anesthetized 
rats may contribute to the fall in the plasma catecholamine level produced 
by i . v . clonidine and further suggests that the hypotensive effect may 
be centrally mediated (Brown and Harland, 1984). 
The centrally mediated fall in blood pressure induced by clonidine 
has been ascribed to a reduced sympathetic nerve act iv i ty . This was shown 
to be dose-dependent after intravenous injection (Waite, 1975) as well 
as after it was injected into the 3rd Ventricle of the brain (Waite, 1975). 
Franz and Madsen (1982) suggested that although the - bulbo-
spinal reflex pathway was- more sensitive to depression by clonidine than 
i ts efferent descending intraspinal pathway, analysis of the relat ive depre-
ssion of transmission at spinal and at brainstem level indicated that the 
spinal site is more sensitive to clonidine than it has been considered 
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Prolonged treatment of spontaneously hypertensive rats with cloni-
dine decreased the mean arter ial pressure and heart rate (Pegram et^  a l . , 
1982). On stopping chronic clonidine treatment, an abrupt rebound of the 
blood pressure to values higher than those recorded before treatment has 
been reported by several authors. 
Adrenergic Link 
Studies have shown that centrally acting agents l ike clonidine 
are usually effective in low doses and that increase in dosage tend to 
exaggerate the possibil i ty of side effects without providing much additional 
antihypertensive efficacy (Schultz et^  al_. , 1981). Titeler and Seeman (1982) 
have suggested that the antihypertensive action of clonidine is more likely 
due to interactions with oC^-adrenergic receptors than oC^-receptors. 
Pharmacological evidence shows that central ©(--adrenoceptor acti-
vation is associated with sedation and reduction in blood pressure (Bousquet 
et a l . . 1983). It has been further suggested that the bradycardiac effect 
of clonidine results from activation of both central and peripheral o i -adre-
nergic receptors of the •'^.-subtype (Park et^  al_. , 1983). Neurotransmitter 
concentration in the synaptic cleft may be responsible for the transsynaptic 
modulation of o( -adrenoceptors postsynaptic population. The fiC -adrenoceptor 
which are presynaptically located on the serotonergic terminals but are 
post-synaptic in relation to the noradrenergic neurons also show increased 
sensit ivi ty after chronic clonidine treatment (Cerrito et_ al_. , 1984). Chronic 
clonidine administration can induce down-regulation of both of_-presynaptic 
autoreceptors located on noradrenaline terminals and of -presynaptic hetro 
receptors located on serotonin terminals (Maura et^  aj_. , 1985). The increased 
pressor resonsiveness of both spontaneously hypertensive ra ts and Wistar-
Kyoto rats to arginine vasopressin following clonidine is an unexpected 
finding and may be related to peripheral interaction between oc-adrenergic 
agonist and arginine vasopressin (Dat-a-r et^  al_. , 1986). 
Cholinergic 
Srimal et^  al_., (1977) suggested that intact cholinergic link in 
the brain stem is essential for the hypotensive action of clonidine. Criscione 
et a l . , (1983) have proposed that cholinergic mechanism in the NTS tends 
tonically to lower ar ter ial pressure after clonidine administration and may 
modulate the baroreceptor reflex without being an integral par t of the 
reflex a r c . 
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Opioid 
Naloxone completely blocked the c lonidine induced hypotens ion 
in spontaneously hype r t ens ive r a t s and c a t s , and p a r t i a l l y b locked i t in 
Wistar Kyoto r a t s , suggesting the pa r t i c ipa t ion of opioid l ink in the d e v e -
lopment of c lonidine evoked b radyca rd i a and hypotension both in h y p e r t e n -
s ive and normotensive an imals . Experiments conducted on anes the t i zed ca t s 
(Rogers and Cubeddu, 1983) show tha t c lonidine a p p a r e n t l y reduces blood 
p r e s s u r e , hea r t r a t e and efferent sympathe t ic nerve f i r i ng , by a mechanism 
independent of an opia te receptor ac t iva t ion wi th in the CNS. Contradic t ing 
t h i s , Er iksson and Tuomisto, (1983) suggested tha t opioid mechanism p o -
s s i b l y p a r t i c i p a t e s in the hypotens ive action of c lon id ine , but l e s s in 
normotensive than in spontaneously h y p e r t e n s i v e an imals . Farsang et_ al_. , 
(1984) i s of the view tha t the haemodynamic differences between the cent -
r a l l y act ing oC -adrenoceptor agonist a n t i h y p e r t e n s i v e drugs may at l eas t 
in p a r t r e s u l t from the involvement of opioid mechanism only in the act ion 
of c lon id ine . 
RESERPINE 
History 
The use of Rauwoiiiahy Indian worke r s was r eco rded in 1918, 
but i t s usefulness in hyper tens ion was pointed out by Vakil in 1949 and 
l a t e r confirmed by Wilkins and Judson (1953). In the e a r l y 19^0, Rauwo^^a 
6Q.n.pZntina p r e p a r a t i o n s and r e s e r p i n e , the main a l k a l o i d , were in t roduced 
for the t rea tment of l ess seve re form of hype r t ens ion . 
Rauwot^a p r epa ra t ions were a lso in t roduced in p s y c h i a t r y for the 
t rea tment of Sch izophren ia . However, g radua l ly r e s e r p i n e passed out of 
p s y c h i a t r i c use and was rep laced by more efficacious syn the t i c drugs (Luby , 
1968). Reserpine continued to be used as a n t i h y p e r t e n s i v e drug . 
MODE OF ACTION 
Depletion of Catecholamines 
Treatment of animals with r e s e r p i n e r e su l t ed in deple t ion of c a t e -
cholamines from the sympathe t ic ganglia , blood v e s s e l s , s p l e e n , i r i s and 
o ther t i s sues wi th an adrenerg ic innervat ion (Berkowitz et^ al_., 1971). 
It a l so dep l e t ed the b r a i n of i t s content of noradrena l ine (Holzbauer and 
Vogt, 1956) and serotonin (Karki and Paasonen, 1959). Reserpine a l so d e p -
le t ed t h e r a b b i t and sheep b ra in of dopamine, which occur red more r a p i d l y 
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than that of noradrenaline (Bertler et^  al_. , 1956). In pigeons, reserpine 
caused depletion of the serotonin of the brain, more rapid ly than dopamine 
and finally noradrenaline (Juorio and Vogt, 1967). 
Kopin and Gordon (1962) showed that the reserpine - induced 
depletion of catecholamines is accompanied by the release of inactive dea-
minated metabolites. Thus the appearance of active catecholamines at the 
site of action is minimal. 
The interaction of reserpine with indirectly acting sympathomimetic 
amines have been reviewed by Muscholl (1966). 
Reduction in Transmission 
The administration of reserpine results in reduction of responses 
of effector organs to stimulation of post ganglionic adrenergic nerves , even 
though the effector organ remains responsive to noradrenaline (Gaffney 
et a l . , 1963). The loss of peripheral adrenergic transmission has a latency 
and occurs sometime after the appearance of the usual signs of the reser-
pine syndrome such as sedation, bradycardia, decrease in blood pressure 
and relaxation of the nictitating membrane. The loss of adrenergic t rans-
mission after reserpine treatment is not complete. Thus, adrenergic nerve 
stimulation sti l l produces positive inotropic responses in guinea pig atria 
(Barnett and Benforado 1966) and chicks heart (Bolton, 1967). But the 
response is abolished in rabbit (Hukovic, 1959). 
Cholinergic Component 
A cholinergic component is reported in the response of the nictitat-
ing membrane of reserpinized cat (Mirkin and Cervoni, 1962). It is sugges-
ted that there are cholinergic fibres running with the adrenergic fibres 
in the sympathetic nerve trunk or a cholinergic mechanism is present in 
the adrenergic nerves (Burn and Rand 1965). 
Effect in Hypertensive Animals 
Reserpine gradually lowers blood pressure without causing an initial 
pressor response in most animals and in man (Bein, 1956). However, a 
primary hypertensive response to reserpine has been observed in spinal 
animals (Schmitt and Schmitt, 1969) and in animals pretreated with ganglion 
blocking drugs (Bech ^ aj^., 1957). Both these procedures result in consi-
derable enhancement of pressor responses to noradrenaline and adrenaline. 
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Reserpine treated r a t s , subjected to procedures for producing renal hyper-
tension failed to become hypertensive. The isolated perfused hind quarters 
of these rats exhibit a lesser vasoconstrictor action of noradrenaline than 
do those of untreated hypertensive r a t s . The hypotensive 
action of reserpine is greater in hypertensive subjects than in normotensive 
ones, although the incidence of side effects does not differ between the 
two groups (Fluckiger, 1969). In spontaneously hypotensive r a t s , reserpine 
has a more pronounced antihypertensive activi ty than in renal hypertensive 
rats (Ebinhera and Martz, 1970). A single dose of 0.05 mg/kg po lowered 
the ar ter ial pressure and reduced the heart rate of dogs with neurogenic 
hypertension, whereas inconsistent effects were obtained with the same 
dose of reserpine in renal hypertensive or normotensive animals (Ehrre ich, 
1978). 
Peripheral Mechanism 
The antihypertensive action of reserpine is often at t r ibuted to 
the loss of vasomotor and cardiac sympathetic tone consequent to the deple-
tion of noradrenaline from the peripheral adrenergic nerves subserving 
cardiovascular control (Green, 1962). 
Central Mechanism 
The depletion of noradrenaline from cardiovascular control centres 
in the hypothalamus, medulla, and from neurons in the lateral horns of 
the spinal cord which make synaptic connection with thoracolumbar sympa-
thetic preganglionic neurones, could also be responsible for the fall in 
blood pressure (Green, 1962). 
Greenberg and Weiss (1979) gave repeated doses of reserpine to 
3 month old rats which produced dose related increase in (3H) dihydro 
alprenolol (DHA) bincjing in pineal gland, cerebral cortex and cerebellum. 
Reserpine increased DHA binding by increasing the density of ^ - a d r e n e r g i c 
receptors , according to these authors. 
Reserpine-induced supersensitivity to isoprenaline does not appear 
to involve a change in the affinity for ^-adrenoceptor or in receptor num-
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ber as determined by ( H) DHA binding (Hawthorn and Broadley, 1982). 
The evidence against the central site of action for the antihyper-
tensive action has been provided by several authors. Thus after treatment 
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with reserpine, no diminution in electrical discharge in the preganglionic 
sympathetic nerves was observed which is expected following depression 
of sympathetic centres (Kobinger and Pichler, 1976). 
The initial enthusiasm for the clinical use of reserpine was dampen-
ed by i ts side effects, in particular severe depression resulting in some 
cases committing suicide. It is now used in combination with other anti-
hypertensives. However, reserpine is a useful pharmacological tool. 
HYDRALAZINE 
History 
The hypotensive effect of hydralazine, which is characterized 
by its gradual onset, limited degree and long duration, was observed in 
the laboratory as early as 1945. But only four years later the first paper 
on this new group of blood pressure lowering agent was published (Gross 
et a l . , 1950). One of the reasons for the delay was unpleasant, acute side 
effects such as headache, nausea, vomitting, flushing, tachycardia and 
angina. 
Mechaitlsm of Action 
The onset of hypotensive action is gradual, the maximum response 
is reached after 10 to 20 min, the degree of blood pressure reduction 
is limited and the duration of action is long. Higher doses do not induce 
a marked fall in blood pressure, but a prolongation of the effect lasting 
for several hours is observed (Gross et^  al_. , 1950; Bein et^  stJL'» 1953). 
In the spinal cat , in which the basal blood pressure is reduced 
to about 50 to 60 mmHg hydralazine does not induce a further fall of blood 
pressure . From this it was erronously concluded that the drug may have 
a central site of action. Although on the basis of the f i rs t pharmacological 
studies of hydralazine i t was supposed that the drug acted directly on 
the arteriolar smooth muscle, some data suggested only a central site of 
action (Gross e^ al_. , 1950; Bein et^  a]_., 1953). 
In further studies hydralazine was administered into a fourth cere-
bral ventricle; , the carotid arteries of cats and the hypotensive response 
obtained was taken as an indication that the drug acted centrally (Lim 
et a l . , 1955). However, other investigators reported contradictory resul ts . 
When hydralazine was injected into the cisterna magna or the th i rd ventricle 
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of ca t s , only a slight fall in the blood pressure was observed accompanied 
by a reduced pressor response to i . v . injected adrenaline (Schmitt and 
Gicguel, 1956). Furthermore injections of hydralazine into the vertebral 
ar tery of the cat caused a similar hypotensive response to intravenous 
injection (van Zwieten, 1968). Increase of the hydralazine dose from 1 
to 2 mg/kg, which resulted in a greater fall in blood pressure , produced 
no significant reduction of spontaneous sympathetic outflow (Baum et_ al_. , 
1972). 
The reduction in the peripheral vascular resistance is the conse-
quence of a general vasodilation of the precapil lary resistant vessels ( Is-
rai l i and Dayton, 1977). Simultaneously with the fall in the blood pressure , 
an increase in the heart rate and cardiac output occurs as a result of 
enhanced peripheral sympathetic act iv i ty . The increase in heart rate is 
more pronounced in the conscious animals than in the anesthetized one 
and is of shorter duration than the fall in blood pressure (Brunner ei_ 
a l . , 1967). Since hydralazine has only a weak action on the capacitance 
vesse ls , venous return is not diminished and cardiac output increased 
simultaneously with the r ise in heart rate (Zacest et^  al_. , 1972). To a 
certain degree the increase in myocardial contractility was repor ted, which 
could be inhibited by <?f-adrenergic blockers (Barrett et_ al_. , 1965). In 
spontaneously hypertensive rats hydralazine lowers blood pressure (Nagaoka 
et_ a l . , 1969). 
Extensive studies of Ablad and associates (1963) have shown that 
hydralazine and related compounds exert their hypotensive effect by means 
of direct action on the vascular smooth muscle. It has no influence on 
centers regulating blood pressure. 
The mechanism of the hypotensive effect of hydralazine in produc-
ing vasodilation both I^L v^vo ^^d on contracted arterial s t r ips is uncertain. 
The scant evidence that exists suggests an interference with the influx 
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of Ca + into the smooth muscle cell or i ts release from intracellular stores 
(Mclean el^ al_. , 1978). 
In conscious rabbi t s , the release of catecholamines and renin asso-
ciated with hydralazine induced hypotension could be blocked by the p ros -
taglandin synthetase inhibitor, indomethacin; the hypotensive responses 
was enhanced (Graham et^  al_., 1979). 
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Shepherd et^  al_. , (1981) have stated that determining the acetylator 
index before giving hydralazine to the hypertensive patient is useful as 
the plasma hydralazine levels depend on the acetylator index hydralazine 
caused a slight increase in plasma renin activity and urinary excretion 
of noradrenaline in patients with essential hypertension (Velasco et_ a]_. , 
1985). 
The increased formation of kinins within the kidney could be invol-
ved in the vasodilator and blood pressure lowering effects of dihydralazine 
as suggested by Boenner et_ al_. , (1982). 
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•^NE 5-HT 
MESENCEPHALON 
PONS 
MEDULLA OBLONGATA 
SPINAL CORD 
Schematic drawing showing, in highly simplified form, the main mono-
amine neuron projection systems in the central nervous system (Anden 
et a l . . 1966). 
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RESULTS 
The c r i t e r i a for receptor cha rac te r i za t ion were ful f i l led as the 
binding s i t e s were found to be r e v e r s i b l e , sa tu rab le and t empera tu re d e -
penden t . The d i s t r ibu t ion of adrenerg ic and dopaminergic r e c e p t o r s in 
normal r a t bra in i s shown in Table 1. The affinily (Kd) of «^-adrenergic 
r e c e p t o r s ranges from 0.i>6 nM to 1.24 nM indicat ing tha t t he se a r e high 
aff ini ty binding s i t e s . The populat ion (Bmax) of these r e c e p t o r s i s f a i r l y 
constant in al l the four a reas ranging from 30.21 to 41.49 p Mol/g t i s s u e . 
The y9-ad rene rg ic r ecep to r s have high aff ini ty binding s i t e s in 
c o r t e x , medul la , hypothalamus and caudate ranging from 0.58 to 1.76 nM. 
Thei r populat ion ranges from 24.88 to 38.76 p Mol/g t i s sue in different 
a r e a s . 
The dopaminergic binding s i t s in caudate show high aff in i ty (0.032 
nM) and high densi ty (58.68 p/Mol/g t i s s u e ) . In the o the r t h r e e a r ea s 
of the r a t b r a i n , the affinity ranges from 0.31-0.43 nM and dens i ty from 
25.23 to 46.63 p Mol/g t i s s u e . 
The changes produced in t he se r e c e p t o r s by chronic admin i s t r a t ion 
of cen thaqu in , c lonidine , hyd ra l az ine or r e se rp ine a re d e s c r i b e d be low. 
CENTHAQUIN 
Effect on cC-Adrenergic Receptors 
Centhaquin did not produce any change in the cor t i ca l of-adrenergic 
r e c e p t o r s . The affinity (Kd) as well a s the populat ion (Bmax) remained 
unchanged. In the caudate nucleus a l s o , t h e r e was no change in t h e af f in i ty 
and dens i ty of these r e c e p t o r s . In the medulla t h e r e was a dec rease (40.91) 
in the aff in i ty but an increase in t h e populat ion. In the hypotha lamus 
the drug decreased (38.2%) the aff ini ty but inc reased (52.4%) the dens i ty 
of t h e s e r e c e p t o r s s ignif icant ly (Table 2; F ig . I & I I ) . 
Effect on ^-Adrenergic Receptors 
Centhaquin did not produce any change in the aff ini ty or the den-
s i t y of any of the four a reas of the b r a i n v i z . c o r t e x , c a u d a t e , medulla 
and hypo tha l amus . 
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Effect on Dopaminergic Receptors 
An insignificant increase in the aff ini ty (Kd) and a s ignif icant 
decrease in the populat ion (Bmax) of the cor t i ca l dopaminergic r e c e p t o r s 
was o b s e r v e d . There was no change in the cauda te , medul lary and h y p o -
thalamic dopaminergic r e c e p t o r s (Table 2jf^^-^ ' ^ 
CLONIDINE 
Effects on oC-Adrenergic Receptors 
There was no change in the aff ini ty or the dens i ty of the oc-adre-
nergic r ecep to r s in the cor tex and the caudate following clonidine t r ea tmen t . 
However, the re was a significant decrease in the aff in i ty and a significant 
increase in the dens i ty of the oC-adrenergic r e c e p t o r s in the medulla and 
hypothalamus (Table 3^ft'^1-
Effects on ^ -Adrenerg ic Receptors 
In none of the four a reas of the b ra in viz c o r t e x , cauda te , medulla 
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and hypotha lamus , t h e r e was any change in the aff ini ty or the dens i ty 
of >^-adrenergic r e c e p t o r s (Table 3; Fig. I l l & IV) on chronic t reatment 
with c lonid ine . 
Effects on Dopaminergic Receptors 
There was no change in the aff ini ty but a s l i g h t increase in the 
dens i ty of the cor t i ca l dopaminergic r e c e p t o r s following chronic t reatment 
wi th clonidine was ob ta ined . In the o the r t h r e e a r e a s of the b ra in v i z . 
cauda te , medulla and hypothalamus no change in t h e af f in i ty or dens i ty 
of the r ecep to r s was o b s e r v e d (Table 3 j A^ • ' ^ ' ^ • ^ 
HYDRALAZINE 
Effects on of-Adrenergic Receptors 
Chronic t reatment of r a t s wi th hyd ra l az ine (0.125 m g / k g / p o / d a y ) 
produced no significant change in the aff ini ty eC-adrenergic r e c e p t o r s in 
any of the four b ra in a r e a s s tud ied but i t could s ign i f ican t ly decrease 
the dens i ty of r e c e p t o r s in the cor tex and the hypothalamus and a s ign i f i -
cant ly increase in caudate and medulla oblongata (Table 4; F ig . I & I I ) . 
Effects on ^ -Adrenerg ic Receptors 
In the cortex , caudate and hypothalamus, hydralazine treatment 
caused an increase in the affinity of beta-adrenergic receptors . There 
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was a lso an increase in the populat ion of ^ - r e c e p t o r s in the cor tex (35.2%), 
caudate (15.9%) and the hypothalamus (28.6%). However, t h e r e was no 
change in the aff ini ty and a decrease in the receptor popula t ion was noted 
in the medulla (Table 4; F ig . I l l & IV) . 
Effects on Dopaminergic Receptors 
The affinity of the cor t i ca l dopaminergic r e c e p t o r s was not changed 
whi le the densi ty decreased (32 .41) . There w a s , howeve r , no change in 
the r e c e p t o r s of caudate nucleus following chronic t rea tment with h y d r a l a -
z ine . In the medulla and the hypo tha lamus , the dens i ty of r e c e p t o r s d e c -
r ea sed by 37.7% and 24.6% r e s p e c t i v e l y whereas the af f in i ty dec reased 
in the medulla (24.8%) and increased in the hypothalamus (Table 4; Fig.V 
& VI) . 
RESERPINE 
Effects on oC-Adrenergic Receptors 
No significant change was o b s e r v e d in t h e aff ini ty of the oC-adreno-
c e p t o r s in any of the four a r ea s of the b ra in v i z . c o r t e x , c a u d a t e , medulla 
and hypothalamus following chronic r e s e r p i n e treatment (12.5 m g / k g / p o / d a y ) . 
The r ecep to r population in the cor tex (27.3%) medulla (36.7%) and h y p o t h a -
lamus (28.0%), however , decreased s ignif icant ly whereas i t i nc reased in 
the caudate (32.1%) (Table 5; F ig . I & I I ) . 
Effects on yo-Adrenergic Receptors 
No significant change occured in the affinity of the > o - r e c e p t o r s 
of c o r t e x , cauda te , medulla and the hypotha lamus . The d e n s i t y of t he se 
r e c e p t o r s , however , inc reased in the cor tex (23.7%), caudate (28.9%) and 
hypothalamus (44.1%) and dec reased in the medulla (32.0%) (Table 5; F ig . 
I l l & IV) . 
Effects on Dopaminergic Receptors 
There was a decrease in t h e affinity of dopaminergic r e c e p t o r s 
in t h e caudate and an increase in the medulla but no change in t h e cor tex 
and hypothalamus following chronic t reatment with r e s e r p i n e . The populat ion 
of t h e s e r e c e p t o r s decreased in t h e cor tex (19.8%) and medulla (16.5%), 
i nc reased in the hypothalamus (24.4%) whi le i t was not affected in t h e 
caudate (Table 5; Fig.IV & V) . 
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Table 1: Dis t r ibu t ion of a lpha and be t a - ad rene rg i c and dopaminergic 
r e c e p t o r s in var ious a reas of the normal r a t b r a in 
Region Receptor Type Affinity Kd 
(nM) 
Population Bmax 
(pMol/g Tissue) 
Cortex oC-adrenergic 
^ - a d r e n e r g i c 
Dopaminergic 
0.81 ± 0.12 30.21 ± 1.38 
0.80 ± 0.11 38.76 ± 2.57 
0.43 ± 0.18 34.86 ± 1.39 
Caudate oC-adrenergic 
y3-adrenergic 
Dopaminergic 
1.24 ± 0.23 41.49 ± 2.19 
1.76 ± 0.14 35.77 ± 1.44 
0.032±0.016 53.03 ± 1.33 
Medulla ^ - ad rene rg i c 
^ - a d r e n e r g i c 
Dopaminergic 
0.66 ± 0.20 31.09 ± 1.30 
0.68 ± 0.12 31.77 ± 1.73 
0.39 ± 0.11 44.49 ± 1.63 
Hypothalamus (Jf-adrenergic 
/S-adrenergic 
Dopaminergic 
0.68 ± 0.11 32.89 ± 2.19 
0.58 ± 0.09 24.88 ± 2.16 
0.31 ± 0 . 0 9 25.23 ± 0.92 
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Table 2: Alteration in (fi- and ^-adrenergic and dopaminergic receptors 
following administration of centhaquin to rats for 2 months at a dose of 
Clmg/kg^c/day 
Region 
Cor tex 
Caudate 
Medulla 
Hypothalamus 
Receptor type 
of-adrenergic 
yS-adrenergic 
Dopaminergic 
oC -adrenergic 
^ - a d r e n e r g i c 
Dopaminergic 
^ - a d r e n e r g i c 
yS-adrenergic 
Dopaminergic 
sx'-adrenergic 
^ - a d r e n e r g i c 
Dopaminergic 
Kd (Percentage) 
Change 
-4 .9 
- 7 . 5 
-18 .6 
+13.7 
-12 .5 
+6.2 
+40.9* 
0.0 
+10.2 
+38.2* 
+13.7 
-3 .2 
Bmax 
(percen tage) 
Change 
- 3 . 9 
+1.9 
-25 .2* 
+7.9 
- 5 . 2 
- 1 . 1 
+85.8* 
- 0 . 2 
- 2 . 5 
+52.4* 
+1.8 
- 1 . 9 
P^1D.05 compared to control 
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Table 3: Alteration in c(-- and ^-adrenergic and dopaminergic receptors 
following chronic administration of clonidine (0. Img/kg/p/day) to r a t s . 
Region 
Cortex 
Caudate 
Medulla 
Hypothalamus 
Receptor Type 
oC-adrenergic 
j 3 - ad rene rg i c 
Dopaminergic 
o(-adrenergic 
^ - a d r e n e r g i c 
Dopaminergic 
of-adrenergic 
yS-adrenergic 
Dopaminergic 
oC-adrenergic 
/^ -adrenergic 
Dopaminergic 
Kd (Percentage) 
Change 
+ 2.4 
-10.0 
+11.6 
+15.3 
+ 7.3 
- 3.1 
+31.8* 
- 2.9 
+10.2 
+27.9* 
+10.3 
+ 3.2 
Bmax 
{Percentage) 
Change 
+ 1.0 
- 1.0 
+17.1* 
+ 9.0 
- 1.5 
- 1.0 
+58.8* 
+ 1.5 
- 1.4 
+31.7* 
- 3.4 
+ 5.7 
* P ^0.05 compared to control. 
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Table 4: Alterat ions in of- a n d ^ ' a d r e n e r g i c and dopaminergic r e c e p t o r s 
following chronic administration" of hyd ra l az ine (8>Jmg/kg/p/day) to r a t s . 
ans 
Region 
Cortex 
Caudate 
Medulla 
Hypothalamus 
Receptor Type 
o( -adrenergic 
jP -adrenerg ic 
Dopaminergic 
oC adrenergic 
^ - a d r e n e r g i c 
Dopaminergic 
o( -adrenerg ic 
^ - a d r e n e r g i c 
Dopaminergic 
©(-adrenergic 
>^-adrenergic 
Dopaminergic 
Kd (Percentage) 
Change 
- 6.1 
-20 .0* 
+ 3.0 
- l / . l 
-15 .9* 
+ 6.2 
- 1.3 
+ 0.5 
+24.8* 
- 4.8 
-20 .0* 
+ 0.6 
Bmax 
(Percentage) 
Change 
-23 .2* 
+35.2* 
-32 .4* 
+25.9* 
+15.9* 
+ 0.8 
+24.4* 
-23 .0* 
-37 .7* 
- 2 8 . 0 1 * 
+28.6* 
-24 .6* 
• < 
* P< 0.05 compared to cont ro l . 
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Table 5: Alteration in <*'- and^-adrenerg ic and dopaminergic receptors 
following chronic administration of Reserpine (lE5nig/kg/p/day) for 
2 months to r a t s . 
Region 
Cortex 
Caudate 
Medulla 
Hypothalamus 
Receptor Type 
of-adrenergic 
^ - a d r e n e r g i c 
Dopaminergic 
o( -adrenergic 
y^-adrenergic 
Dopaminergic 
of-adrenergic 
^ - a d r e n e r g i c 
Dopaminergic 
cC-adrenergic 
^ - a d r e n e r g i c 
Dopaminergic 
Kd (Percentage) 
Change 
- 1.2 
-15 .0 
0 . 0 
-13 .2 
- 9.7 
+28.1* 
+17.9 
-12 .6 
-23 .0* 
-17 .2 
- 4.8 
+ 4.5 
Bmax 
{Percentage) 
Change 
- 2 7 . 3 * 
+23.7* 
-19 .85* 
+32.1* 
+28.9* 
- 3.8 
-36 .7* 
-32 .0* 
- 1 6 . 5 * 
-37 .2* 
+44.1* 
+24.4* 
* P^O.65 compared to control. 
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DISCUSSION 
Till recently most investigations have been confined to study 
the process of neurotransmitter synthesis , frequency of nerve impulse, 
the process of release of neurotransmitter and its uptake mechanism or 
enzymatic degradation. Not much attention has been paid to the status 
of the receptors in the brain of the hypertensive subjects or the change 
following antihypertensive therapy. With the development and use of ligand 
binding studies, it is now possible to precisely determine the state of 
the receptors including their affinity and number in any particular area 
of the brain. 
The use of ligand binding technique to study neurotransmitter rece-
ptor sites has led to a broad range of important biological advances. 
It is now possible to obtain information about regional distribution of 
neurotransmitter receptors in brain, the pharmacological, biochemical and 
developmental characteristics of these s i t es , and the functional inter-rela-
tionship between neuronal cell types . The main limitation of radioreceptor 
assays is their specificity since any substance having an appreciable affi-
nity for the neurotransmitter receptor site will displace the specifically 
bound ligand. Thus before routinely using a radio receptor assay, precau-
tions must be taken to ensure that the only substance in the sample that 
will interfere with the ligand binding is the substance being analysed. 
Because of the high specific activity of neurotransmitter radioligands, 
the radioreceptor assay procedure is very sensit ive, being able to readily 
detect picomole quantities of the compound. 
Radio receptorassay. is also simple, inexpensive and rapid in that 
hundreds of samples can be analysed in a single day. Studies using radio 
receptor assays have been reported as analytical tools indicating the ver-
satali ty and usefulness of this procedure in neuro-chemical investigations. 
In the present investigation radio ligand binding technique has 
been used to determine the differences in the receptor affinity and popula-
tion between normal rats and those treated with the antihypertensive drugs. 
It is farily well established that receptor population a l ters in an inverse 
manner to changes in neural impulse flow (Morris et_ al_., 1981). It i s , 
therefore, clear that the change in the radioreceptor binding will indirectly 
reflect the neuronal ac t iv i ty . 
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The drugs investigated in the present study are some ant i -hyper-
tensive drugs like centhaquin, clonidine, hydralazine and reserpine on 
the adrenergic and dopaminergic receptors . The selection of the drugs 
has been guided by an effort to ensure that they act by different mechani-
sms so that changes in receptors will probably reflect as much effect 
of reduced blood pressure as the effect of drugs themselves. 
Centhaquin has been reported to lower blood pressure by acting 
mainly in the brain (Srimal e^ aj_. , 1978). The results indicate that it 
has i ts action mainly on the of-adrenergic receptors of the medulla and 
the hypothalamus. These areas are involved in cardiovascular regulation 
(Muira et_ aj_. , 197i). and i t could be possible that centhaquin produces 
hypotension by acting on the oC^adrenergic receptors in these a reas . Several 
studies indicate that oC-adrenergic receptors in the nucleus tractus solita-
rious (dejong, 1974) and ventral surface of medulla (Zhang and Cir ie l lo , 
1982; McAllen et_ aj_. , 1982) are involved in the cardiovascular regulation. 
In this study no attempt was made to dissect out different areas of the 
medulla for preparing membranes and therefore, it is not possible to detect 
changes in individual areas of the medulla. Only the overall changes have 
been detected. 
Centhaquin caused an increase in the population of alpha-adreno-
ceptors of medulla and hypothalamus but their affinity had gone down. 
Such a situation can arise only if there is a reduced amouht of the neuro-
transmitter available under the effect of the drug. It is possible that 
centhaquin may be acting on the presynaptic alpha-adrenergic receptors 
and decreasing the release of adrenergic neurotransmitter which has resulted 
in an increase in the density of post-synaptic of-adrenergic receptors . 
Centhaquin has not produced any change in the adrenergic and 
dopaminergic receptors of cortex and the caudate suggesting that these 
areas are not involved in its action. 
Clonidine has been claimed to stimulate the central oC-adrenoceptors 
to produce hypotension (Hausler, 1974). It has also been reported by 
Medgett and Rand (1983) that the cardiovascular effects of clonidine are 
not related to decrease in central noradrenaline turnover, due to the fact 
that cardiovascular effects of this drug can be elicited even in the absence 
of neural noradrenaline. 
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The hypotension resulting after the chronic administration of small 
doses of clonidine is associated with a reduction in the preganglionic splan-
chnic nerve discharge indicating a reduction in the central sympathetic 
tone. Transection experiments indicate that the medullary and the hypotha-
lamic centres are involved in this response (Schmitt and Schmitt, 1969). 
The affinity of clonidine for presynaptic oC-adrenergic receptors 
is atleast ten times higher than i ts affinity for postsynaptic flC-adrenocep-
tors (Starke ei_ aj_. , 1974). Therefore, it could be possible that it may 
be acting on the presynaptic alpha-adrenergic receptors , thus decreasing 
the release of adrenergic neurotransmitter resulting in the increase in 
the density of the post-synaptic alpha-adrenergic receptors , as observed 
in this study. Like centhaquin, clonidine also decreased the affinity of 
the receptors located in the medulla and the hypothalamus and increased 
their population, indicating a decrease in the neural transmission. An inc-
rease in the population of dopaminergic receptors in the cerebral cortex 
by clonidine treatment may be unrelated to i ts cardiovascular actions since 
it is also known to cause sedation and affect release of other neurotrans-
mitters like acetylcholine etc. 
Reserpine depletes the stores of catecholamines and 5-hydroxy-
tryptamine in the brain as well as peripherally and most of i ts pharma-
cological effects have been attributed to this action (Juoria and Vogt, 
1967). In the present study reserpine was found to decrease the density 
of the e<-adrenergic, ^6-adrenergic as well as dopaminergic receptors of 
the medulla and the of-adrenergic and dopaminergic receptors of the cortical 
region of the brain. The oC-adrenoceptors of the hypothalamus were also 
decreased but ^-adrenoceptors and dopaminergic receptors were increased. 
The action of reserpine on the central nervous system (CNS) app-
ears not to play a major role in the reduction of sympathetic nerve act ivi ty . 
There may even be an increase in sympathetic out flow (Iggo and Vogt, 
1960). Reserpine prevents the storage of catecholamines without effecting 
their synthesis by adrenergic neurons. It i s , therefore, assumed that this 
leaves more free noradrenaline to react with the receptor . This could 
also par t ia l ly explain the central hypotensive action of reserpine. 
The effect of reserpine is not confined to catecholamines alone, 
it also depletes 5-HT in the brain and depression and suicidal tendency 
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in the patients has been attributed to this effect (Doyle et^  a]_, , 1955). 
Antidepressants are now known to down regulate vS-adrenoceptors and upre-
gulate 5-HT receptors in the cortex. The present study has demonstrated 
an increase in the population of ^-adrenoceptors in the cortex, the hypo-
thalamus and the caudate which could part ial ly explain the depressant 
effect of reserpine. The effect of reserpine on 5-HT receptors has not 
been studied but presumably they should be upregulated like oc-adrenergic 
receptors . 
After chronic administration of hydralazine, there is a fall in 
blood pressure , with an increase in the heart rate and the cardiac output. 
This occurs as a result of reflex enhanced peripheral sympathetic act ivi ty 
following fall of blood pressure due to peripheral vasodilation (Brunner 
et a l . , 1967). The increase in myocardial contractility could be inhibited 
by oC-adrenergic antagonists (Barrett et^  £1^., 1965). The present study 
has shown that the density of the oC-adrenergic receptors increased in 
the caudate and the medulla and decreased in hypothalamus and cortex. 
In case of the ^-adrenergic receptors , their density increased in the cortex 
and caudate and decreased in medulla and hypothalamus. In the dopaminer-
gic receptors a decrease in the density has been observed in the cortex, 
medulla and the hypothalamus. The varied effect of hydralazine on Ct-
and J^ -adrenoceptors and dopaminergic receptors in different areas of 
the brain could be viewed as the response of the brain to the chronic 
hypotensive stage. Hydralazine presumably does not effect specifically 
any of the central neurotransmitters and lowers the blood pressure by 
peripheral effects alone (Ablad, 1963). It will be interesting to study 
the effect of some other direct vasodilators which . lower blood pressure 
by peripheral mechanisms only. The changes in the receptor population 
are an indirect reflection on the state of neurotransmitter avai labi l i ty 
of the receptor site in response to lowered blood pressure which the 
cardiovascular centers will t ry to bring back to normal. It must, however, 
be emphasised that no drug affects only one function and therefore changes 
in the receptor population in the medulla and the hypothalamus may reflect 
changes secondary to hypotension while changes in cortex and caudate 
may reflect changes in other body functions. 
Thus it seems that centhaquin and clonidine have a central mode 
of action, while reserpine and hydralazine, which are per ipheral ly acting 
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drugs, produce a generalised effect. Also that centhaquin and clonidine 
produce the effect primarily in the medulla and in the hypothalamus, 
whereas reserpine and hydralazine do not have a limited effect on a pa r t i -
cular area of the brain. 
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